NAT-SUNITINIB
Analogs of NAT-SUNITINIB
Find cheaper analogs and generic equivalents for NAT-SUNITINIB.
Active Ingredient: SUNITINIB (SUNITINIB MALATE)
Product Overview
About NAT-SUNITINIB
NAT-SUNITINIB is a prescription medication containing the active ingredient SUNITINIB (SUNITINIB MALATE), a tyrosine kinase inhibitor used in the treatment of certain types of cancer. It is specifically indicated for the treatment of gastrointestinal stromal tumors (GIST) and advanced renal cell carcinoma (RCC).
Key Benefits & Uses
- Treatment of gastrointestinal stromal tumors (GIST)
- Treatment of advanced renal cell carcinoma (RCC)
- Targeted therapy for cancer patients with specific genetic mutations
Active Ingredient & Action
SUNITINIB (SUNITINIB MALATE) works by inhibiting multiple tyrosine kinases, including vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptors (PDGFRs). This action helps to slow down the growth and spread of cancer cells, ultimately leading to tumor shrinkage and improved patient outcomes.
Important Notes
NAT-SUNITINIB is available in capsule form and should be taken orally once daily. It is essential to follow the prescribed dosage and treatment schedule as directed by your healthcare provider. Common side effects may include fatigue, diarrhea, and hypertension. Patients should be closely monitored for signs of adverse reactions and adjust their treatment plan accordingly. Consult your doctor or pharmacist for more information on the safe use of NAT-SUNITINIB.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.